BioAtla (NASDAQ:BCAB) PT Lowered to $7.00BioAtla (NASDAQ:BCAB - Free Report) had its price objective lowered by HC Wainwright from $10.00 to $7.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a buy rating...
Ticker Report•4 months ago